Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
38
days
Real-World Effectiveness of Tezepelumab in Severe Asthma: A 12-Month Canadian Cohort Study
Authors
Mathieu D Saint-Pierre; Samih Agaybi; Catherine B Charron; Jean-Grégoire LeducShow moreShow less
Affiliations
1. Respirology, Montfort Hospital, University of Ottawa, Ottawa, ON, Canada; 2. Respirology, Orleans Cardiopulmonary Group, Ottawa, ON, CanadaShow moreShow less
95
days
Dupilumab Treatment is Associated with Improvement in Small Airway Dysfunction in Children with Moderate to Severe Asthma: A Retrospective Analysis
Authors
Lihong Sun; Lijun Zeng; Lanying Cheng; Xu Qin; Kaijia Yang; Yueying Yang; Fengyi Gong; Jinping Zheng; Nanshan ZhongShow moreShow less
Affiliations
1. Department of Pediatric Pulmonology, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong, 510000, People’s Republic of China; 2. Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong, 510000, People’s Republic of ChinaShow moreShow less
190
days
Adherence to Inhaled Corticosteroids and Inflammatory Phenotypes in Asthma
Authors
Christiane Hammershaimb Mosbech; Kjell Erik Julius Håkansson; Erik Sören Halvard Hansen; Howraman Meteran; Peter Ascanius Jacobsen; Nicklas Brustad; Erica Woer Brask; Laurits Janns; Christian Grabow Westergaard; Nina Skavlan Godtfredsen; Charlotte Suppli UlrikShow moreShow less
Affiliations
1. Department of Respiratory Medicine, Copenhagen University Hospital - Hvidovre, Hvidovre, Denmark; 2. Department of Respiratory Diseases, Aalborg University Hospital, Aalborg C, Denmark; 3. Faculty of Medicine, Aalborg University, Aalborg Ø, Denmark; 4. Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Copenhagen University Hospital - Herlev and Gentofte, Gentofte, Denmark; 5. Allergy and Lung Clinic, Helsingør, Denmark; 6. Department of Clinical Medicine, University of Copenhagen, Copenhagen, DenmarkShow moreShow less
39
days
Real-World Comparative Effectiveness of Mepolizumab versus Benralizumab in an Older Population with Asthma: A US Medicare Fee-for-Service Analysis
Authors
Guillaume Germain; Emmeline Burrows; Jacob Klimek; Patrick Gravelle; Kioumars Tavakoli Tafti; François Laliberté; Arijita DebShow moreShow less
Affiliations
1. Group d’analyse SRI, Montréal, Québec, Canada; 2. US Medical Affairs, GSK, Durham, NC, USA; 3. Analysis Group, Inc, Boston, MA, USA; 4. Analysis Group ULC, Toronto, Ontario, Canada; 5. Global Real-World Evidence & Health Outcomes Research, GSK, Upper Providence, PA, USAShow moreShow less
84
days
Unique Associations Between Complement Split Products and Pollen Species in Adults with Respiratory Allergic Disease: A Pilot Study
Authors
Sairaman Nagarajan; Tamar Smith-Norowitz; Martin H Bluth; Andrew Eng; Yosif Pak; Stephan Kohlhoff; Rauno JoksShow moreShow less
Affiliations
1. Department of Medicine, SUNY Downstate Health Sciences University, New York, NY, 11203, USA; 2. Department of Pediatrics, SUNY Downstate Health Sciences University, New York, NY, 11203, USA; 3. Department of Pathology, SUNY Health Sciences University, New York, NY, 11203, USA; 4. Department of Pathology, Maimonides Medical Center, New York, NY, 11219, USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days